摘要
急性心肌梗死并发缓慢性心律失常的情形并不少见,此类心律失常多数可在缺血病因纠正后恢复,但也可能进展为不可逆性的传导异常。患者的预后与心肌梗死的部位、传导异常的类型以及再灌注治疗的时效等密切相关。心脏起搏器是症状性或致命性心动过缓最有效的治疗手段,但心肌梗死急性期心律失常的演变存在逆转、进展或反复等可能,起搏器的实际应用仍面临诸多难以决策的问题,权威指南之间亦有争议。现对于急性心肌梗死并发缓慢性心律失常的研究进展以及起搏治疗现状做一综述。
Bradyarrhythmias are not an uncommon complication in patients with acute myocardial infarction.In the majority of cases,bradyarrhythmias can be corrected by treating the underlying cause of ischemia,however,it may also progress to irreversible conduction abnormality.The prognosis of patients is closely related to the region of infarcted myocardium,the type of conduction disturbance,as well as the time to reperfusion and treatment effect,et al.Even though pacing is the most useful intervention for symptomatic or life-threatening bradyarrhythmias,conduction disorder is likely to be reversed,progressive or relapse during the acute phase of myocardial infarction.The clinical decision-making process of pacing therapy in the setting of acute myocardial infarction is not easy,and disputes exist even among authoritative guidelines.This paper aimed at reviewing the research progress and pacing therapy status in patients with acute myocardial infarction complicated with bradyarrhythmias.
作者
杨毓秀
贾镭
张峻
李佳
宋卫华
窦克非
尹栋
YANG Yuxiu;JIA Lei;ZHANG Jun;LI Jia;SONG Weihua;DOU Kefei;YIN Dong(Fuwai Hospital,National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100037,China)
出处
《心血管病学进展》
CAS
2022年第12期1057-1062,共6页
Advances in Cardiovascular Diseases
基金
中国医学科学院医学与健康科技创新工程项目(2020-I2M-C&T-B-056)。
